Vnitr Lek 2023, 69(8):E26-E29 | DOI: 10.36290/vnl.2023.109

Vascular changes that may affect the prognosis of patients and that could also be looked for by an internist, diabetologist, lipidologist or general practitioner

Jiří Matuška
Angiologická ambulance, MATMED, s. r. o., Hodonín

Early diagnosis of preclinical atherosclerosis should lead to intervention of lifestyle and eating habits and, in most cases, to the initiation of hypolipidemic therapy. Current ambulatory diagnostic options are greatly expanded by the use of cheap and simple handheld ultrasounds/smaller ultrasound devices. The detection of atherosclerotic plaque on peripheral arteries is a clear factor emphasizing the need for adequate therapy of dyslipidemia. The general availability and reasonable imaging quality of simple pocket ultrasounds will probably lead to their expansion to a level corresponding to the current use of the phonedoscope.

Keywords: atherosclerosis, cardivascular risk, dyslipidemia, polyvascular disease, ultrasound examination, vascular screening.

Accepted: December 5, 2023; Published: December 18, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matuška J. Vascular changes that may affect the prognosis of patients and that could also be looked for by an internist, diabetologist, lipidologist or general practitioner. Vnitr Lek. 2023;69(8):E26-29. doi: 10.36290/vnl.2023.109.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76(25):2982-3021.
    2. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020;41(1):111-188. Go to original source... Go to PubMed...
    3. Cardiovascular diseases statistics. Eurostat 2023. Available at: https://ec.europa.eu/eurostat/statistics­‑explained/index.php?title=Cardiovascular_diseases_statistics. Accessed November 15, 2023.
    4. Drozd M, Pujades­‑Rodriguez M, Sun F, Franks KN, Lillie PJ, Witte KK, et al. Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc., DiS. 2021;10(22). doi:10.1161/JAHA.121.023188. Go to original source... Go to PubMed...
    5. Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart Br. Card. Soc. 2016;102(24):1945-1952. Go to original source... Go to PubMed...
    6. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau C­‑S, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events­‑study design. Am. Heart J. 2006;151(4):786.e1-10. Go to original source... Go to PubMed...
    7. Gutierrez JA, Aday AW, Patel MR, Jones WS. Polyvascular Disease. Circ. Cardiovasc. Interv. 2019;12(12):e007385. Go to original source... Go to PubMed...
    8. Výsledky zdravotnických účtů ČR v letech 2010 až 2018. Čes. Stat. Úř. 202AD. Available at: https://www.czso.cz/csu/czso/vysledky­‑zdravotnickych­‑uctu­‑cr-2010-2018. Accessed November 14, 2023.
    9. Santos JV, Vandenberghe D, Lobo M, Freitas A. Cost of cardiovascular disease prevention: towards economic evaluations in prevention programs. Ann. Transl. Med. 2020;8(7):512. Go to original source... Go to PubMed...
    10. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021;42(34):3227-3337. Go to original source... Go to PubMed...
    11. Fowkes FGR, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta­‑analysis. JAMA 2008;300(2):197-208.
    12. Clairotte C, Retout S, Potier L, Roussel R, Escoubet B. Automated ankle­‑brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients. Diabetes Care 2009;32(7):1231-1236. Go to original source... Go to PubMed...
    13. Homza M, Machaczka O, Porzer M, Kozak M, Plasek J, Sipula D. Comparison of different methods of ABI acquisition for detection of peripheral artery disease in diabetic patients. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2019;163(3):227-232. Go to original source... Go to PubMed...
    14. Yamada H, Ito H, Fujiwara M. Cardiac and vascular point­‑of­‑care ultrasound: current situation, problems, and future prospects. J. Med. Ultrason. 2001 2022;49(4):601-608. Go to original source... Go to PubMed...
    15. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2008;21(2):93-111; quiz 189-190. Go to original source... Go to PubMed...
    16. Bluth EI. Evaluation and characterization of carotid plaque. Semin. Ultrasound. CT MR 1997;18(1):57-65. Go to original source... Go to PubMed...
    17. Ariyoshi K, Okuya S, Kunitsugu I, Matsunaga K, Nagao Y, Nomiyama R, et al. Ultrasound analysis of gray­‑scale median value of carotid plaques is a useful reference index for cerebro­‑cardiovascular events in patients with type 2 diabetes. J. Diabetes Investig. 2015;6(1):91-97. Go to original source... Go to PubMed...
    18. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid Plaque, Intima Media Thickness, Cardiovascular Risk Factors, and Prevalent Cardiovascular Disease in Men and Women. Stroke 1999;30(4):841-850. Go to original source... Go to PubMed...
    19. Rogers SK, Phair A, Carriera J, Ghosh J, Bowling FL, McCollum C. Feasibility and Accuracy of Measuring Carotid Plaque Volume (Burden) With Contrast­‑Enhanced Tomographic 3D Ultrasound and Ultrasound Image Fusion. Ann. Vasc. Surg. 2023;91:168-175. Go to original source... Go to PubMed...
    20. Phair AS, Carreira J, Bowling FL, Ghosh J, Smith C, Rogers SK. Accelerated Measurement of Carotid Plaque Volume Using Artificial Intelligence Enhanced 3D Ultrasound. Ann. Vasc. Surg. 2023. doi:10.1016/j.avsg.2023. 06. 018. Go to original source...
    21. Näslund U, Ng N, Lundgren A, Fhärm E, Grönlund C, Johansson H, et al. Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open­‑label, randomised controlled trial. Lancet Lond. Engl. 2019;393(10167):133-142. Go to original source... Go to PubMed...
    22. Holmberg H, Sjölander M, Glader E­‑L, Näslund U, Carlberg B, Norberg M, et al. Time to initiation of lipid­‑lowering drugs for subclinical atherosclerosis: sub­‑study of VIPVIZA randomized controlled trial, with single­‑arm cross­‑over. Eur. Heart J. Open 2022;2(1). doi:10.1093/ehjopen/oeac003. Go to original source... Go to PubMed...
    23. Waterhouse DF, Cahill RA, Sheehan F, Sheehan SJ. Concomitant detection of systemic atherosclerotic disease while screening for abdominal aortic aneurysm. World J. Surg. 2006;30(7):1350-1359. Go to original source... Go to PubMed...
    24. Dodge M, Movahed MR. Screening of the Abdominal Aorta During Routine Echocardiographic Examination Is Cost­‑effective and Leads to Increase in Statin Utilization by Detecting Subclinical Atherosclerosis. Crit. Pathw. Cardiol. 2021;20(1):1-3. Go to original source... Go to PubMed...
    25. Cheong BYC, Wilson JM, Spann SJ, Pettigrew RI, Preventza OA, Muthupillai R. Coronary artery calcium scoring: an evidence­‑based guide for primary care physicians. J. Intern. Med. 2021;289(3):309-324. Go to original source... Go to PubMed...
    26. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, et al. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi­‑Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J. Am. Coll. Cardiol. 2015;66(15):1643-1653. Go to original source... Go to PubMed...
    27. Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet Lond. Engl. 2016;388(10059):2532-2561. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.